Genomic instability and innate immune responses to self-DNA in progeria

Abstract

In the last decade, we have seen increasing evidence of the importance of structural nuclear proteins such as lamins in nuclear architecture and compartmentalization of genome function and in the maintenance of mechanical stability and genome integrity. With over 400 mutations identified in the LMNA gene (encoding for A-type lamins) associated with more than ten distinct degenerative disorders, the role of lamins as genome caretakers and the contribution of lamins dysfunction to disease are unarguable. However, the molecular mechanisms whereby lamins mutations cause pathologies remain less understood. Here, we review pathways and mechanisms recently identified as playing a role in the pathophysiology of laminopathies, with special emphasis in Hutchinson Gilford Progeria Syndrome (HGPS). This devastating incurable accelerated aging disease is caused by a silent mutation in the LMNA gene that generates a truncated lamin A protein "progerin" that exerts profound cellular toxicity and organismal decline. Patients usually die in their teens due to cardiovascular complications such as myocardial infarction or stroke. To date, there are no efficient therapies that ameliorate disease progression, stressing the need to understand molecularly disease mechanisms that can be targeted therapeutically. We will summarize data supporting that replication stress is a major cause of genomic instability in laminopathies, which contributes to the activation of innate immune responses to self-DNA that in turn accelerate the aging process.

BRCA1-Associated Protein Is a Potential Prognostic Biomarker and Is Correlated With Immune Infiltration in Liver Hepatocellular Carcinoma: A Pan-Cancer Analysis

“…Tumor immunology is a trending topic in cancer research. Immune-related mechanisms play important roles in multiple pathophysiological progresses (Rožman, 2018;Gonzalo and Coll-Bonfill, 2019;Walker et al, 2019), and immunotherapeutic strategies are considered as a promising direction for the treatment of many cancers (Washah et al, 2020). Immunotherapy, such as programmed death-1 (PD-1) and programmed death ligand-1 (PD-L1) inhibitors, plays a good anti-tumor effect in the treatment of malignant tumors, such as lung cancer (Cheng et al, 2020;Eguren-Santamaria et al, 2020) and melanoma (Cuevas and Daud, 2018;Albershardt et al, 2020).…”

JAK3 and TYK2 Serve as Prognostic Biomarkers and Are Associated with Immune Infiltration in Stomach Adenocarcinoma

“…Janus kinases (JAKs) are major activators of signal transducers and play a significant role in cellular biological processes, inflammation, and immunity [ 4 – 7 ]. JAK/STAT signaling is a key regulator of gene expression, transcriptional programs, and immune response.…”

Peer Review #3 of "A signature of tumor DNA repair genes associated with the prognosis of surgically-resected lung adenocarcinoma (v0.1)"

“…Thus, a signature based on multi-gene cooperation can improve the predictive ability of each gene, resulting in a more reliable and robust predictive ability versus a single biomarker (Ashley 2015;Jiang et al 2020;Wolfe et al 2020;Zhu et al 2016). DNA damage repair genes are needed to maintain cell homeostasis and are extensively involved in cell replication, chromatin modification, DNA repair, checkpoint signaling, reactive oxygen species, metabolism, senescence, and apoptosis cellular mechanisms (Brinkman et al 2020;Csiszar et al 2019;Gonzalo & Coll-Bonfill 2019;Lee et al 2018;Royce et al 2019;Ungvari et al 2019). Genetic mutations can effectively induce tumorigenesis and progression (Pearl et al 2015).…”